Transfusion therapy in solid organ transplantation

摘要: Numerous transfusion issues arise in the support of solid organ transplantation. ABO and HLA can cause graft rejection immunity or problems support. Blood usage has been reduced by use erythropoietin renal failure aprotinin during liver transplants. Multifactorial coagulopathy transplant surgery continues to be a challenge requiring close monitoring, however. The beneficial effect transfusions on survival lessened recent years, but remains an area active research.